Leung AWY, Chan RSM, Sea MMM, Woo J (2017) An overview of factors associated with adherence to lifestyle modification programs for weight management in adults
Least-squares mean percentage changes in body weight at week 48 were 8.7% (1 mg), 17.1% (4 mg), 22.8% (8 mg), and 24.2% (12 mg), compared with 2.1% in the placebo arm
UK Legal and Regulatory Context In the United Kingdom, retatrutide is not approved for human therapeutic use by the Medicines and Healthcare products Regulatory Agency (MHRA)
Continued Progress as Medication Reaches Therapeutic Levels Most medications used in this program require gradual titration
Dosing considerations for a theoretical combined protocol No established protocol exists for combining tesamorelin and retatrutide
[DOI] [PubMed] [Google Scholar] 154